Soft Gel Technologies, Inc.® Awarded U.S. Patent for Soft Gelatin Formulation of Injuv® Low Molecular Weight Hyaluronic Acid

LOS ANGELES, CA, December 1, 2004—Soft Gel Technologies, Inc.® (SGTI®) was awarded U.S. Patent #6,806,259 for their Injuv® soft gelatin capsule formulation preparation to provide the primary benefit of internally softening the human skin. Injuv® is a low molecular weight hyaluronic acid (HA) cosmeceutical extracted from rooster combs. It uses a sophisticated enzyme-cleaving process that reduces hyaluronic acid into lower molecular weight polymers which are capable of absorption through oral administration, but does not alter its chemical composition in any way. The most important biological function of hyaluronic acid is its ability to retain fluids in the tissues throughout the entire body. Hyaluronic acid is found in the synovial fluid, the cartilage, the skin, and the vitreous humor of the eye. It is also essential for the structure of the extracellular matrix, which forms a network to maintain fluid balance, particularly in the skin. Hyaluronic acid is responsible for keeping the skin moist and supple. When taken orally, Injuv® provides internal moisture for the body with proven bioavailability.

This patent follows previous patents awarded to SGTI® for GlucoTrim®, CoQsol®, and Isomer E™. Soft Gel Technologies, Inc.® is the exclusive source for Injuv® in soft gelatin capsules. Injuv® is a registered trademark of SGTI®.

SGTI® President, Ron Udell, remarked, “This additional patent strengthens SGTI®’s position as a leading source for unique, clinically-proven, effective nutraceuticals.” SGTI® is committed to providing the natural products industry with proven ingredients and expanding and protecting its intellectual property. Mr. Udell added, “We have just completed a clinical trial with an Injuv® formulation, and the results on improving skin appearance and texture were considered significant by the researchers. ”

About Soft Gel Technologies, Inc.®
Soft Gel Technologies, Inc.® is a leading contract manufacturer providing specialty soft gelatin encapsulation to the nutraceutical industry. SGTI®’s leading product is a patented highly bio-available CoQ10 soft gel marketed as CoQsol®. Other key products include GlucoTrim®, a banaba leaf extract for blood glucose management and Injuv®, a low molecular weight hyaluronic acid for cosmeceutical and joint health applications. Soft Gel Technologies, Inc.® is a privately held company based in Los Angeles, CA.

For more information, visit


Kenn Israel
Director of Marketing
(323) 726-0700
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.